Skip to main content

Advertisement

Log in

Outcomes of initial-onset acute uveitis associated with Vogt–Koyanagi–Harada disease occurred during pregnancy

  • Original Paper
  • Published:
International Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

To investigate the outcomes of initial-onset acute uveitis associated with Vogt–Koyanagi–Harada (VKH) disease that occurred during pregnancy.

Methods

This is a retrospective case series.

Results

During the period between January 2001 and December 2021, we identified 112 patients with initial-onset acute uveitis associated with VKH disease, 67 (59.8%) were females. Among the female patients, 10 (14.9%) patients (20 eyes) were pregnant. Of these patients, 5 patients presented in the first trimester, 3 in the second trimester and 2 in the third trimester. The follow-up period ranged from 8 to 108 months (mean 35.2 ± 28.3 months). At presentation, 8 (80%) patients had initial-onset acute VKH disease with anterior segment (AS) inflammation and 2 (20%) initial-onset acute VKH disease without AS inflammation. All patients were initially treated with systemic corticosteroids combined with cyclosporine. During follow-up period, none of the patients with initial-onset acute VKH disease without AS inflammation developed any complications. Complications including "sunset glow fundus" in 8 (40%) eyes, cataract in 2 (10%) eyes and subretinal fibrosis in 1 (5%) eye were recorded in patients with initial-onset acute VKH disease with AS inflammation. Four (40%) patients developed pregnancy-related complications, including abortion in 1 patient, systemic hypertension in 1 patient and premature rupture of membrane in 2 patients. There were no documented congenital anomalies in all born babies. Best-corrected visual acuity of ≥ 20/20 was achieved in 16 (80%) eyes at the final follow-up.

Conclusion

Primary treatment with combined systemic corticosteroids and cyclosporine in initial-onset acute uveitis associated with VKH disease was safe and effective.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Gocho K, Kondo I, Yamaki K (2001) Identification of autoreactive T cells in Vogt–Koyanagi–Harada disease. Invest Ophthalmol Vis Sci 42:2004–2009

    CAS  Google Scholar 

  2. Yamaki K, Gocho K, Hayakawa K, Kondo I, Sakuragi S (2000) Tyrosinase family proteins are antigens specific to Vogt-Koyanagi-Harada disease. J Immunol 165:7323–7329. https://doi.org/10.4049/jimmunol.165.12.7323

    Article  CAS  Google Scholar 

  3. Yamaki K, Kondo I, Nakamura H, Miyano M, Konno S, Sakuragi S (2000) Ocular and extraocular inflammation induced by immunization of tyrosinase related protein 1 and 2 in Lewis rats. Exp Eye Res 71:361–369. https://doi.org/10.1006/exer.2000.0893

    Article  CAS  Google Scholar 

  4. Fang W, Yang P (2008) Vogt–Koyanagi–Harada syndrome. Curr Eye Res 33:517–523. https://doi.org/10.1080/02713680802233968

    Article  CAS  Google Scholar 

  5. Yang P, Ren Y, Li B, Fang W, Meng Q, Kijlstra A (2007) Clinical characteristics of Vogt–Koyanagi–Harada syndrome in Chinese patients. Ophthalmology 114:606–614. https://doi.org/10.1016/j.ophtha.2006.07.040

    Article  Google Scholar 

  6. Abu El-Asrar AM, Al Tamimi M, Hemachandran S, Al-Mezaine HS, Al-Muammar A, Kangave D (2013) Prognostic factors for clinical outcomes in patients with Vogt–Koyanagi–Harada disease treated with high-dose corticosteroids. Acta Ophthalmol 91:e486–e493. https://doi.org/10.1111/aos.12127

    Article  CAS  Google Scholar 

  7. Park YJ, Park KH, Woo SJ (2017) Clinical features of pregnancy-associated retinal and choroidal diseases causing acute visual disturbance. Korean J Ophthalmol 31:320–327. https://doi.org/10.3341/kjo.2016.0080

    Article  Google Scholar 

  8. El-Asrar AM, Struyf S, Kangave D, Al-Obeidan SS, Opdenakker G, Geboes K, Van Damme J (2011) Cytokine profiles in aqueous humor of patients with different clinical entities of endogenous uveitis. Clin Immunol 139:177–184. https://doi.org/10.1016/j.clim.2011.01.014

    Article  CAS  Google Scholar 

  9. Abu El-Asrar AM, Berghmans N, Al-Obeidan SA, Mousa A, Opdenakker G, Van Damme J, Struyf S (2016) The cytokine interleukin-6 and the chemokines CCL20 and CXCL13 are novel biomarkers of specific endogenous uveitic entities. Invest Ophthalmol Vis Sci 57:4606–4613. https://doi.org/10.1167/iovs.16-19758

    Article  CAS  Google Scholar 

  10. Abu El-Asrar AM, Struyf S, Van den Broeck C, Van Damme J, Opdenakker G, Geboes K, Kestelyn P (2007) Expression of chemokines and gelatinase B in sympathetic ophthalmia. Eye (Lond) 21:649–657. https://doi.org/10.1038/sj.eye.6702342

    Article  CAS  Google Scholar 

  11. Buyon JP, Nelson JL, Lockshin MD (1996) The effects of pregnancy on autoimmune diseases. Clin Immunol Immunopathol 78:99–104. https://doi.org/10.1006/clin.1996.0018

    Article  CAS  Google Scholar 

  12. Wilder RL (1998) Hormones, pregnancy, and autoimmune diseases. Ann N Y Acad Sci 840:45–50. https://doi.org/10.1111/j.1749-6632.1998.tb09547.x

    Article  CAS  Google Scholar 

  13. Snyder DA, Tessler HH (1980) Vogt–Koyanagi–Harada syndrome. Am J Ophthalmol 90:69–75

    Article  CAS  Google Scholar 

  14. Steahly LP (1990) Vogt–Koyanagi–Harada syndrome and pregnancy. Ann Ophthalmol 22:59–62

    CAS  Google Scholar 

  15. Miyata N, Sugita M, Nakamura S, Isobe K, Matoba H, Tsuda K, Ohno S (2001) Treatment of Vogt–Koyanagi–Harada’s disease during pregnancy. Jpn J Ophthalmol 45:177–180. https://doi.org/10.1016/s0021-5155(00)00357-9

    Article  CAS  Google Scholar 

  16. Doi M, Matsubara H, Uji Y (2000) Vogt–Koyanagi–Harada syndrome in a pregnant patient treated with high-dose systemic corticosteroids. Acta Ophthalmol Scand 78:93–96. https://doi.org/10.1034/j.1600-0420.2000.078001093.x

    Article  CAS  Google Scholar 

  17. Sugita K, Mizumoto K, Kato N, Zako M (2015) Early resolution of subretinal fluid without high-dose corticosteroids in a pregnant patient with Vogt–Koyanagi–Harada disease: a case report. J Ophthalmic Inflamm Infect 5:20. https://doi.org/10.1186/s12348-015-0050-3

    Article  CAS  Google Scholar 

  18. Nakamura T, Keino H, Okada AA (2018) Sub-tenon triamcinolone acetonide injection in a pregnant patient with Vogt–Koyanagi–Harada disease. Retin Cases Brief Rep 12:375–378. https://doi.org/10.1097/ICB.0000000000000510

    Article  Google Scholar 

  19. Ingolotti M, Schlaen BA, Roig Melo-Granados EA, Ruiz Garcia H, Aguilera Partida JA (2019) Azathioprine During the First Trimester of Pregnancy in a Patient with Vogt–Koyanagi–Harada Disease: A Multimodal Imaging Follow-Up Study. Am J Case Rep 20:300–305. https://doi.org/10.12659/AJCR.914281

    Article  Google Scholar 

  20. Nohara M, Norose K, Segawa K (1995) Vogt–Koyanagi–Harada disease during pregnancy. Br J Ophthalmol 79:94–95. https://doi.org/10.1136/bjo.79.1.94

    Article  CAS  Google Scholar 

  21. Sato S, Tamaru H (1986) Incomplete type Harada’s disease in early pregnant stage treated with topical corticosteroid. Nippon Ganka Kiyo (Folia Ophthalmol Jpn) 37:46–50

    Google Scholar 

  22. Taguchi C, Ikeda E, Hikita N, Mochizuki M (1999) A report of two cases suggesting positive influence of pregnancy on uveitis activity. Nippon Ganka Gakkai Zasshi 103:66–71

    CAS  Google Scholar 

  23. Ohta K, Gotoh N, Yonezawa H, Oka K, Ashida T (2007) Fetal death following high-dose systemic steroid therapy in a pregnant patient with Vogt–Koyanagi–Harada disease. Nippon Ganka Gakkai Zasshi 111:959–964

    Google Scholar 

  24. Yamagami S, Mochizuki M, Ando K (1991) Systemic corticosteroid therapy for pregnant patients with Vogt–Koyanagi–Harada syndrome. Rinsho Ganka (Jpn J Clin Ophthalmol) 85:52–62

    Google Scholar 

  25. Watase S, Kawamura K, Iseki N (1995) A case of Harada disease during pregnancy treated with systemic corticosteroid drugs. Nippon Ganka Kiyo (Folia Ophthalmol Jpn) 46:1192–1195

    Google Scholar 

  26. Matsubara S, Kuwata T, Ohkawara Y, Makino S (2011) Headache in late pregnancy: a symptom for Vogt–Koyanagi–Harada disease. Arch Gynecol Obstet 283:1423–1425. https://doi.org/10.1007/s00404-010-1748-y

    Article  Google Scholar 

  27. Wakefield D, Abu El-Asrar A, McCluskey P (2012) Treatment of severe inflammatory eye disease in patients of reproductive age and during pregnancy. Ocul Immunol Inflamm 20(4):277–287. https://doi.org/10.3109/09273948.2012.684736

    Article  CAS  Google Scholar 

  28. Jabs DA, Nussenblatt RB, Rosenbaum JT, Standardization of Uveitis Nomenclature Working G (2005) Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 140:509–516. https://doi.org/10.1016/j.ajo.2005.03.057

  29. Buyon JP (1998) The effects of pregnancy on autoimmune diseases. J Leukoc Biol 63:281–287. https://doi.org/10.1002/jlb.63.3.281

    Article  CAS  Google Scholar 

  30. Doria A, Iaccarino L, Arienti S, Ghirardello A, Zampieri S, Rampudda ME, Cutolo M, Tincani A, Todesco S (2006) Th2 immune deviation induced by pregnancy: the two faces of autoimmune rheumatic diseases. Reprod Toxicol 22:234–241. https://doi.org/10.1016/j.reprotox.2006.04.001

    Article  CAS  Google Scholar 

  31. Elenkov IJ, Hoffman J, Wilder RL (1997) Does differential neuroendocrine control of cytokine production govern the expression of autoimmune diseases in pregnancy and the postpartum period? Mol Med Today 3:379–383. https://doi.org/10.1016/s1357-4310(97)01089-7

    Article  CAS  Google Scholar 

  32. Elenkov IJ, Wilder RL, Bakalov VK, Link AA, Dimitrov MA, Fisher S, Chrousos GP (2001) IL-12, TNF-alpha, and hormonal changes during late pregnancy and early postpartum: implications for autoimmune disease activity during these times. J Clin Endocrinol Metab 86:4933–4938. https://doi.org/10.1210/jcem.86.10.7905

    Article  CAS  Google Scholar 

  33. Keeling SO, Oswald AE (2009) Pregnancy and rheumatic disease: “by the book” or “by the doc.” Clin Rheumatol 28:1–9. https://doi.org/10.1007/s10067-008-1031-9

    Article  Google Scholar 

  34. Jara LJ, Vera-Lastra O, Miranda JM, Alcala M, Alvarez-Nemegyei J (2001) Prolactin in human systemic lupus erythematosus. Lupus 10:748–756. https://doi.org/10.1191/096120301717164994

    Article  CAS  Google Scholar 

  35. Ostensen M, Villiger PM, Forger F (2012) Interaction of pregnancy and autoimmune rheumatic disease. Autoimmun Rev 11:A437-446. https://doi.org/10.1016/j.autrev.2011.11.013

    Article  CAS  Google Scholar 

  36. Rabiah PK, Vitale AT (2003) Noninfectious uveitis and pregnancy. Am J Ophthalmol 136:91–98. https://doi.org/10.1016/s0002-9394(03)00110-7

    Article  Google Scholar 

  37. AlBloushi AF, Alfawaz AM, Al-Dahmash SA, Al Owaifeer AM, AlEnezi SH, Al-Fakhri AS, Abu El-Asrar AM (2019) Incidence, risk factors and surgical outcomes of cataract among patients with uveitis in a University Referral Hospital in Riyadh, Saudi Arabia. Ocul Immunol Inflamm 27:1105–1113. https://doi.org/10.1080/09273948.2018.1504970

    Article  Google Scholar 

  38. Park YJ, Park KH, Woo SJ (2017) Clinical features of pregnancy-associated retinal and choroidal diseases causing acute visual disturbance. Korean J Ophthalmol 31(4):320–327. https://doi.org/10.3341/kjo.2016.0080

    Article  Google Scholar 

  39. Friedman Z, Granat M, Neumann E (1980) The syndrome of Vogt–Koyanagi–Harada and pregnancy. Metab Pediatr Ophthalmol 4:147–149

    CAS  Google Scholar 

  40. Norose K, Yano A, Wang XC, Tokushima T, Umihira J, Seki A, Nohara M, Segawa K (1994) Dominance of activated T cells and interleukin-6 in aqueous humor in Vogt–Koyanagi–Harada disease. Invest Ophthalmol Vis Sci 35:33–39

    CAS  Google Scholar 

  41. Stirrat GM (1994) Pregnancy and immunity. BMJ 308:1385–1386. https://doi.org/10.1136/bmj.308.6941.1385

    Article  CAS  Google Scholar 

  42. Chiam NP, Lim LL (2014) Uveitis and gender: the course of uveitis in pregnancy. J Ophthalmol 2014:401915. https://doi.org/10.1155/2014/401915

    Article  Google Scholar 

  43. Sammaritano LR, Bermas BL, Chakravarty EE et al (2020) American college of rheumatology guideline for the management of reproductive health in rheumatic and musculoskeletal diseases. Arthritis Rheumatol 72(4):529–556

    Article  Google Scholar 

  44. Prieto-Peña D, Calderón-Goercke M, Adán A et al (2021) Efficacy and safety of certolizumab pegol in pregnant women with uveitis. Recommendations on the management with immunosuppressive and biologic therapies in uveitis during pregnancy. Clin Exp Rheumatol 39(1):105–114

    Article  Google Scholar 

  45. Abu El-Asrar AM, Dosari M, Hemachandran S, Gikandi PW, Al-Muammar A (2017) Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of “sunset glow fundus” in initial-onset acute uveitis associated with Vogt–Koyanagi–Harada disease. Acta Ophthalmol 95:85–90. https://doi.org/10.1111/aos.13189

    Article  CAS  Google Scholar 

  46. Armenti VT, Ahlswede KM, Ahlswede BA, Jarrell BE, Moritz MJ, Burke JF (1994) National transplantation Pregnancy Registry–outcomes of 154 pregnancies in cyclosporine-treated female kidney transplant recipients. Transplantation 57:502–506

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The study is supported by King Saud University through Vice Deanship of Research Chair, Dr. Nasser Al Rashid Research Chair in Ophthalmology (Abu El-Asrar MA), Riyadh, Saudi Arabia.

Funding

The study is supported by King Saud University through Vice Deanship of Research Chair, Dr. Nasser Al Rashid Research Chair in Ophthalmology (Abu El-Asrar MA), Riyadh, Saudi Arabia.

Author information

Authors and Affiliations

Authors

Contributions

AZA and AIA collected the data and wrote the manuscript. AFA, NFA and AMA interpreted and analyzed the data. All the authors critically edited the manuscript for intellectual content. All the authors read and approve the final manuscript.

Corresponding author

Correspondence to Ahmed M. Abu El-Asrar.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This study was performed in line with the principles of the Declaration of Helsinki and has been evaluated by the Institutional Review Board at King Abdulaziz University Hospital and deemed not to require ethics approval.

Consent to participate

Informed consent was obtained from all individual participants included in the study.

Consent to publish

Consent for publication was obtained.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alromaih, A.Z., Almater, A.I., Albloushi, A.F. et al. Outcomes of initial-onset acute uveitis associated with Vogt–Koyanagi–Harada disease occurred during pregnancy. Int Ophthalmol 43, 185–195 (2023). https://doi.org/10.1007/s10792-022-02415-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10792-022-02415-1

Keywords

Navigation